Literature DB >> 34950287

Cutaneous Conundrums in Cardiac Sarcoidosis: A Series on Skin Disease in Immunosuppression.

Daisy Young1, Sri Harsha Kanuri2, Krishna Akella2, Ghulam Murtaza2, Rakesh Gopinathannair2, Dhanunjaya Lakkireddy2.   

Abstract

Sarcoidosis is a complex systemic condition resulting in formation of non-caseating granulomas. Infiltrative disease in cardiac sarcoidosis can have significant ramifications on mortality and is one of the few indications for systemic immunosuppressive therapy. In the patient on immunosuppressive medication, resultant sequelae such as skin and soft tissue infections are common and must be differentiated from cutaneous forms of sarcoidosis and other skin pathologies. Patients with humoral or cellular immunodeficiencies may have cutaneous lesions secondary to endemic fungi, mycobacterium, viral diseases, parasites, or encapsulated organisms. We report a rare case of cardiac sarcoidosis on immunosuppressive therapy, with a series of cutaneous sequelae due to opportunistic infection.

Entities:  

Keywords:  Atrial fibrillation; Atrial flutter; Cardiac Sarcoidosis

Year:  2020        PMID: 34950287      PMCID: PMC8691317          DOI: 10.4022/jafib.2247

Source DB:  PubMed          Journal:  J Atr Fibrillation        ISSN: 1941-6911


  15 in total

1.  HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis.

Authors:  David H Birnie; William H Sauer; Frank Bogun; Joshua M Cooper; Daniel A Culver; Claire S Duvernoy; Marc A Judson; Jordana Kron; Davendra Mehta; Jens Cosedis Nielsen; Amit R Patel; Tohru Ohe; Pekka Raatikainen; Kyoko Soejima
Journal:  Heart Rhythm       Date:  2014-05-09       Impact factor: 6.343

2.  Histoplasmosis-related Healthcare Use, Diagnosis, and Treatment in a Commercially Insured Population, United States.

Authors:  Kaitlin Benedict; Karlyn D Beer; Brendan R Jackson
Journal:  Clin Infect Dis       Date:  2020-03-03       Impact factor: 9.079

3.  Generalized herpes simplex virus infection in an immunocompromised patient--report of a case and review of the literature.

Authors:  Georg Werner Herget; Ursus Nikolaus Riede; Annette Schmitt-Gräff; Michael Lübbert; Dieter Neumann-Haefelin; Gabriele Köhler
Journal:  Pathol Res Pract       Date:  2005       Impact factor: 3.250

Review 4.  Nocardiosis: updates and clinical overview.

Authors:  John W Wilson
Journal:  Mayo Clin Proc       Date:  2012-04       Impact factor: 7.616

Review 5.  Difficult treatment issues in sarcoidosis.

Authors:  R P Baughman; J P Lynch
Journal:  J Intern Med       Date:  2003-01       Impact factor: 8.989

6.  Mycophenolate mofetil may serve as a steroid-sparing agent for sarcoidosis.

Authors:  D J Kouba; D Mimouni; A Rencic; H C Nousari
Journal:  Br J Dermatol       Date:  2003-01       Impact factor: 9.302

7.  CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis.

Authors:  Simon Greulich; Claudia Christina Deluigi; Steffen Gloekler; Andreas Wahl; Christine Zürn; Ulrich Kramer; Detlev Nothnagel; Helmut Bültel; Julia Schumm; Stefan Grün; Peter Ong; Anja Wagner; Steffen Schneider; Kai Nassenstein; Meinrad Gawaz; Udo Sechtem; Oliver Bruder; Heiko Mahrholdt
Journal:  JACC Cardiovasc Imaging       Date:  2013-03-14

Review 8.  Case reports of heart failure after therapy with a tumor necrosis factor antagonist.

Authors:  Hyon J Kwon; Timothy R Coté; Michael S Cuffe; Judith M Kramer; M Miles Braun
Journal:  Ann Intern Med       Date:  2003-05-20       Impact factor: 25.391

9.  Cardiac sarcoidosis: a comprehensive review.

Authors:  Vishal Sekhri; Shireen Sanal; Lawrence J Delorenzo; Wilbert S Aronow; George P Maguire
Journal:  Arch Med Sci       Date:  2011-09-02       Impact factor: 3.318

10.  Diagnosis of cutaneous sarcoidosis; clinical and the prognostic significance of skin lesions.

Authors:  Halil Yanardag; Cuneyt Tetikkurt; Muammer Bilir; Sabriye Demirci; Aydin Iscimen
Journal:  Multidiscip Respir Med       Date:  2013-03-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.